Immunotherapeutic imides/amides
US5703098A · kind A · utility
57Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 1996 |
| Grant date | Dec 30, 1997 |
| Priority date | — |
| Expiry date | Dec 3, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Imide/amide ethers and alcohols are inhibitors of cytokines including tumor necrosis factor .alpha. and can be used to combat cachexia, endotoxic shock, arthritis, asthma, and retrovirus replication. A typical embodiment is 3-Phthalimido-3-(3', 4'-dimethoxyphenyl)propan-1-ol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.